Europese richtlijnen
2024 – EASL Clinical Practice Guidelines on genetic cholestatic liver diseases
https://www.journal-of-hepatology.eu/article/S0168-8278(24)00274-5/fulltext
2023 – EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
https://www.journal-of-hepatology.eu/article/S0168-8278(23)00181-2/fulltext
2022 – EASL Clinical Practice Guidelines on sclerosing cholangitis
https://www.journal-of-hepatology.eu/article/S0168-8278(22)00326-9/fulltext
2020 – European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations
https://journals.sagepub.com/doi/full/10.1177/2050640620934911
2017 – EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
https://www.journal-of-hepatology.eu/article/s0168-8278(17)30186-1/fulltext
2017 – EASL and ESGE guideline. Role of Endoscopy in Primary Sclerosing Cholangitis.
https://www.journal-of-hepatology.eu/article/s0168-8278(17)30108-3/fulltext
2009 – EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
https://www.journal-of-hepatology.eu/article/S0168-8278(09)00309-2/fulltext
Amerikaanse richtlijnen
2023 – AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
https://journals.lww.com/hep/Fulltext/2023/02000/)
2021 – Primary Biliary Cholangitis: 2021 Practice Guidance Update
https://journals.lww.com/hep/fulltext/2022/04000/primary_biliary_cholangitis__2021_practice.24.aspx
2018 – Guidance on Primary Biliary Cholangitis
https://journals.lww.com/hep/Fulltext/2019/01000/Primary_Biliary_Cholangitis__2018_Practice.32.aspx
